CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice
- PMID: 22552859
- DOI: 10.1007/s10875-012-9699-7
CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice
Abstract
Increasing studies have demonstrated that atherosclerosis is a chronic immunoinflammatory disease, and that oxidized low-density lipoprotein (oxLDL)-specific T cells contribute to the autoimmune process in atherosclerosis. Oral administration of oxLDL, which was identified as a candidate autoantigen in atherosclerosis, was shown to induce tolerance and suppress atherogenesis. However, the precise mechanisms of mucosal tolerance induction, in particular nasal tolerance, remain unknown. In this study, we explored the effect of nasal oxLDL on atherosclerosis as well as the cellular and molecular mechanisms leading to atheroprotective responses, and then found that nasal oxLDL drastically ameliorate the initiation (47.6 %, p < 0.001) and progression (21.1 %, p = 0.001) of atherosclerosis. Most importantly, a significant 35.8 % reduction of the progression of atherosclerosis was observed in the enhanced immunization group (p < 0.001). These effects were accompanied by a significant increase in CD4(+) latency-associated peptide (LAP)(+) regulatory T cells (Tregs) and CD4(+)CD25(+)Foxp3(+) Tregs in spleens and cervical lymph nodes, together with increased transforming growth factor (TGF)-β production and suppressed T-helper cells type 1, 2, and 17 immune responses. Surprisingly, neutralization of TGF-β in vivo partially counteracted the protective effect of nasal oxLDL treatment, indicating that the presence of TGF-β was indispensable to CD4(+)LAP(+) Tregs and CD4(+)CD25(+)Foxp3(+) Tregs to acquire regulatory properties. Our studies suggest that CD4(+)LAP(+) Tregs and CD4(+)CD25(+)Foxp3(+) Tregs induced by nasal delivery of oxLDL can inhibit oxLDL-specific T cells response and ameliorate atherosclerosis process.
Similar articles
-
Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.Clin Exp Immunol. 2016 Mar;183(3):452-68. doi: 10.1111/cei.12726. Epub 2015 Nov 24. Clin Exp Immunol. 2016. PMID: 26452441 Free PMC article.
-
Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.Circulation. 2006 Oct 31;114(18):1968-76. doi: 10.1161/CIRCULATIONAHA.106.615609. Epub 2006 Oct 23. Circulation. 2006. PMID: 17060383
-
Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4+CD25+Foxp3+ regulatory T cells.Toxicol Lett. 2019 Nov;316:27-34. doi: 10.1016/j.toxlet.2019.09.005. Epub 2019 Sep 9. Toxicol Lett. 2019. PMID: 31513887
-
Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.Expert Rev Cardiovasc Ther. 2008 Aug;6(7):987-97. doi: 10.1586/14779072.6.7.987. Expert Rev Cardiovasc Ther. 2008. PMID: 18666849 Review.
-
FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13. Transpl Immunol. 2012. PMID: 21939765 Review.
Cited by
-
Treating atherosclerosis with regulatory T cells.Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7. doi: 10.1161/ATVBAHA.114.303568. Epub 2014 Nov 20. Arterioscler Thromb Vasc Biol. 2015. PMID: 25414253 Free PMC article. Review.
-
Vaccination against atherosclerosis.Curr Opin Immunol. 2019 Aug;59:15-24. doi: 10.1016/j.coi.2019.02.008. Epub 2019 Mar 29. Curr Opin Immunol. 2019. PMID: 30928800 Free PMC article. Review.
-
2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis.Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):429-38. doi: 10.1161/ATVBAHA.115.306009. Epub 2016 Jan 28. Arterioscler Thromb Vasc Biol. 2016. PMID: 26821946 Free PMC article.
-
Vaccination in Atherosclerosis.Cells. 2020 Nov 30;9(12):2560. doi: 10.3390/cells9122560. Cells. 2020. PMID: 33266027 Free PMC article. Review.
-
Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study.PLoS One. 2014 Feb 18;9(2):e88775. doi: 10.1371/journal.pone.0088775. eCollection 2014. PLoS One. 2014. PMID: 24558424 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous